Profile
ABIO NVO VRTX REGN MRNA SGEN
Company Name ARCA biopharma, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $47.66M $579.91B $126.85B $115.26B $46.43B $43.15B
Employees 0.00K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. Thomas A. Keuer Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
ABIO NVO VRTX REGN MRNA SGEN
Quant Rating Score 3 5 4 4 3 3
Quant Rating Neutral Strong Buy Buy Buy Neutral Neutral
Trading
ABIO NVO VRTX REGN MRNA SGEN
Last Close $3.285 $131.54 $491.57 $1063.6 $121.14 $228.74
High 52 $4 $199.54 $492.13 $1100.05 $166.61 $228.9
Low 52 $1.58 $87.78 $340.48 $727.13 $69.51 $191.57
Price vs. 52 Week High -17.88 % -34.08 % -0.11 % -3.31 % -27.29 % -0.07 %
Price vs. 52 Week Low 107.91 % 49.85 % 44.38 % 46.27 % 74.28 % 19.4 %
Total Return
ABIO NVO VRTX REGN MRNA SGEN
1 Month Return -6.14 % -7.34 % 4.88 % 0.99 % -9.19 % 0 %
3 Month Return -4.78 % 5.01 % 22.92 % 18.16 % 15.97 % 0 %
6 Month Return 104.04 % 24.69 % 11.69 % 12.81 % 21.5 % 0 %
9 Month Return 61.82 % 36.61 % 35.85 % 31.56 % 50.67 % 6.14 %
YTD Return 93.24 % 27.15 % 20.81 % 21.1 % 21.81 % 0 %
1 Year Return 61.03 % -20.6 % 35.62 % 44.78 % -4.18 % 17.51 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABIO NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.15 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.1 % 8.49 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ABIO NVO VRTX REGN MRNA SGEN
Asset Growth -12.12 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth 2.63 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth - 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year - 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year - 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth 31.14 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth 42.32 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share 82.09 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share 96.41 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share 99.63 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth 31.14 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) 54.05 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG 78.79 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG 96.75 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG 99.55 % 150.92 % 6084.35 % 713.56 % -4698.89 % -2622.09 %
EPS Growth 42.19 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth 42.19 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -11.2 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -74 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share -67.24 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share -98.87 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth - 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth 54.06 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ABIO NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM 42.61 % 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -14.93 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -14.68 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -22.72 % 82.5 % 20.67 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 91.3 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 75.19 % 101.7 % 114.62 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM -4535.23 % 45.03 % 40.85 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -10306.25 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM - 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 0.19 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM - 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM 733.33 % 248.64 % 685.31 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 0.48 % 81.71 % 42.57 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -0.34 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -0.34 11.28 13.48 36.87 -9.61 -3.73
Cash Per Share TTM 247.59 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -2810.8 % 38.24 % 38.74 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 53.85 % 88.22 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -10306.25 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -9.63 78.98 36.46 29 -12.64 -61.54
Price To Operating Cash Flows Ratio TTM -9.63 43.03 32.18 24.19 -16.06 -79.67
Price Cash Flow Ratio TTM -9.63 43.03 32.18 24.19 -16.06 -79.67
Income Statement (TTM)
ABIO NVO VRTX REGN MRNA SGEN
Revenue $0B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $-0B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.01B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.01B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -0.37 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ABIO NVO VRTX REGN MRNA SGEN
Long Term Debt $0B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.04B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.04B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ABIO NVO VRTX REGN MRNA SGEN
Net Income $-0.01B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.43
ABCL AbCellera Biologics Inc. 2.97
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.11
ABOS Acumen Pharmaceuticals, Inc. 2.87
ABSI Absci Corporation 3.97
ABUS Arbutus Biopharma Corporation 3.69
ABVC ABVC BioPharma, Inc. 0.826
ABVX Abivax SA American Depositary Shares 12.4
ACAD ACADIA Pharmaceuticals Inc. 17.75
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.24
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.8352
ACHV Achieve Life Sciences, Inc. 4.63
ACIU AC Immune SA 3.48
ACLX Arcellx, Inc. 62.56
ACRV Acrivon Therapeutics, Inc. Common Stock 7.33
ACST Acasti Pharma Inc. 2.84
ACXP Acurx Pharmaceuticals, Inc. 2.43
ETFs With Exposure to ABIO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 271.06
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 120.37
VXF Vanguard Extended Market Index Fund 0 175.3
IWC iShares Micro-Cap ETF 0.00855 123.586
DFAT Dimensional U.S. Targeted Value ETF 0.00017546 54.77
VTSAX Vanguard Total Stock Market Index Fund 0 131.88
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 132.99
VITSX Vanguard Total Stock Market Index Fund 0 131.9
DFSU Dimensional US Sustainability Core 1 ETF 0.0000013 35.43
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000237478 93.14
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 133
SOLR SmartETFs Sustainable Energy II ETF 2.24 27.62
DCOR Dimensional ETF Trust 0.00000603 60.5589
VEMPX Vanguard Extended Market Index InstlPlus 0 328.19
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 247.41
Unlock